Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.47 |
| ▸ | PIN4 | Q9Y237 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29000793 | 0.80 | ALDH1A1 (0.72) | NPSR1ALDH1A1CA12CA9KMT2A | |
| SCHEMBL24370526 | 0.78 | NPSR1 (0.46) | NPSR1ALDH1A1POLBKMT2AMEN1 | |
| SCHEMBL521967 | 0.78 | ALDH1A1 (0.83) | NPSR1ALDH1A1POLBCA12CA9 | |
| SCHEMBL11453331 | 0.76 | ALDH1A1 (0.77) | NPSR1ALDH1A1CA12CA9KMT2A | |
| SCHEMBL1775902 | 0.76 | CA12 (0.66) | NPSR1ALDH1A1POLBCA12CA9 | |
| SCHEMBL10455469 | 0.75 | ALDH1A1 (0.78) | NPSR1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL10455775 | 0.75 | ALDH1A1 (0.78) | NPSR1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL24370564 | 0.74 | ALDH1A1 (0.63) | NPSR1ALDH1A1CA12CA9KMT2A | |
| SCHEMBL1757448 | 0.74 | ALDH1A1 (0.64) | NPSR1ALDH1A1POLBCA12CA9 | |
| SCHEMBL20083679 | 0.74 | ALDH1A1 (0.63) | NPSR1ALDH1A1CA12CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127228-A1 | METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT | SOOCHOW UNIVERSITY (CN) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127228-A1 | METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT | AOC1, AOC2, AOC3 | NPSR1 4673/4885ALDH1A1 31/4885POLB 1293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.